The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

NCT07095933 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy
Drug Resistant

Interventions

DRUG: Everolimus

Sponsor

Xuanwu Hospital, Beijing